The global in-vitro toxicology testing market is expanding due to the rising demand for in-vitro toxicology testing products worldwide. In addition, the market growth is anticipated to be driven by the rapidly expanding pharmaceutical and medical industries. River Laboratories (U.S.), and Lonza (Switzerland), among others, are some of the major international players that make up the fragmented global in-vitro toxicology testing market. These players are present on a regional and global scale, so suppliers and manufacturers can offer goods with various features and specifications for all price ranges.
Access full Report @ https://www.databridgemarketresearch.com/fr/reports/global-vitro-toxicology-testing-market
Data Bridge Market Research analyses that the Global In-Vitro Toxicology Testing Market is expected to reach USD 27,952.36 million by 2030, at a CAGR of 12.3% during the forecast period of 2023 to 2030. The demand for efficient and reliable testing methods for drug development and safety screening is contributing to the market's growth, as in-vitro tests provide rapid and accurate results.
Key Findings of the Study
Cost-effectiveness is expected to drive the market's growth rate
In-vitro toxicology testing provides a cost-effective alternative to traditional animal testing methods. It eliminates the need for expensive animal models, reduces the costs associated with housing and caring for animals, and minimizes the logistical challenges related to animal experiments. Moreover, in-vitro testing allows researchers to conduct multiple tests simultaneously, saving time and resources. The cost-effectiveness of in-vitro testing makes it an attractive option for researchers and manufacturers, particularly in resource-limited settings, without compromising the quality and accuracy of toxicological assessments.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, and Pricing in USD
|
|
Segments Covered
|
Product and Service (Consumables, Services, Assays, Equipments, and Software), Toxicology End Point and Test (ADME (Absorption, Distribution, Metabolism, and Excretion) Testing, Cytotoxicity Testing, Genotoxicity Testing, Dermal Toxicity Testing, Ocular Toxicity Testing, Organ Toxicity Testing, Skin Irritation, Corrosion, and Sensitization Testing, Phototoxicity Testing, and Other Toxicity Endpoints & Tests), Technology (Cell Culture, High-Throughput Technologies, Molecular Imaging, and Omics Technology), Method (Cellular Assays, Biochemical Assays, Ex-Vivo Models, and In Silico Models), Industry (Pharmaceutical and Biopharmaceutical Companies, Diagnostics, Food, Chemicals, Cosmetics and Household Products), Distribution Channel (Direct Tender, Retail Sales, and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Thermo Fisher Scientific Inc. (U.S.), Labcorp Drug Development (U.S.), Merck KGaA (Germany), Charles River Laboratories (U.S.), Lonza (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Catalent, Inc (U.S.), SGS Société Générale de Surveillance SA (Switzerland), QIAGEN (Netherlands), Intertek Group plc. (U.K.), Eurofins Scientific (Luxembourg), Promega Corporation (U.S.), Aragen Life Sciences Ltd. (U.S.), Cyprotex Plc. (U.K.), Shanghai Medicilon Inc. (China), Creative Biolabs (U.S.), BioIVT (U.S.), AAT Bioquest, Inc. (U.S.), Gentronix (U.K.), IONTOX (U.S.), InSphero (Switzerland), MB Research Laboratories (U.S.), Creative Bioarray (U.S.), Preferred Cell Systems (U.S.) among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The global in-vitro toxicology testing market is segmented on the basis of product and service, toxicology end point and test, technology, method, industry, and distribution channel.
- On the basis of product and service, the global in-vitro toxicology testing market is segmented into consumables, services, assays, equipment’s, and software.
- On the basis of toxicology end point and test, the market is segmented into ADME (absorption, distribution, metabolism, and excretion) testing, cytotoxicity testing, genotoxicity testing, dermal toxicity testing, ocular toxicity testing, organ toxicity testing, skin irritation, corrosion, and sensitization testing, phototoxicity testing, and other toxicity endpoints & tests.
- On the basis of technology, the market is segmented into cell culture technologies, high-throughput technologies, molecular imaging, and OMICS technology.
- On the basis of method the market is segmented into cellular assays, biochemical assays, ex-vivo models, and in silico models.
- On the basis of industry the market is segmented into pharmaceutical and biopharmaceutical companies, diagnostics, food, chemicals, cosmetics and household products.
- On the basis of distribution channel, the market is segmented into direct tender, retail sales, and others.
Major Players
Data Bridge Market Research recognizes the following companies as the major in-vitro toxicology testing market players in in-vitro toxicology testing market are Bio-Rad Laboratories, Inc. (U.S.), Catalent, Inc (U.S.), SGS Société Générale de Surveillance SA (Switzerland), QIAGEN (Netherlands), Intertek Group plc. (U.K.), Eurofins Scientific (Luxembourg), Promega Corporation (U.S.)
Market Developments
- In 2023, Lonza, a global manufacturing partner to the pharmaceutical, biotech, and nutraceutical markets, announced it had acquired Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage technology platform for developing ADCs.
- In 2022, Thermo Fisher Scientific Inc. announced that it will expand its laboratory operations in Highland Heights, Kentucky, helping customers deliver life-changing medicines to patients. The current facility, which includes central lab and biomarker operations, provides biopharma customers with high-quality laboratory services to accelerate drug development.
- In 2022, Laboratory Corporation of America Holdings acquired AtlantiCare diagnostic clinical laboratory services.
- In 2021, Laboratory Corporation of America Holdings Acquired Myriad Autoimmune’s Vectra Testing Business, autoimmune business unit, including the Vectra rheumatoid arthritis (RA) assay.
- In 2020, Merck KGaA acquired BSSN Software, a German laboratory informatics company, for ease of data integration, collaboration, analysis, and long-term archiving in laboratories.
- In 2019, Charles River Laboratories acquired Citoxlab, a non-clinical CRO, for USD 494 million (EUR 448 million).
Regional Analysis
Geographically, the countries covered in the in-vitro toxicology testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is expected to dominate the region in in-vitro toxicology testing market during the forecast period 2023-2030
North America is poised to dominate the global in-vitro toxicology testing market due to several factors. The region is experiencing a significant rise in the demand for toxicology testing, driven by the need for more efficient and reliable methods of evaluating potential toxic effects of chemicals and substances. Technological advancements in the field are further boosting market growth, as researchers and manufacturers seek innovative and accurate testing solutions. Within North America, the U.S. is expected to lead the market, fueled by the increasing adoption of in-vitro toxicology testing products and services across various industries and research sectors.
Asia-Pacific is estimated to be the fastest-growing region in in-vitro toxicology testing market in the forecast period 2023-2030
Asia-Pacific is expected to grow during the forecast period due to China being projected to dominate the Asia-Pacific region in the in-vitro toxicology testing market as key market players are actively implementing strategic initiatives, expanding their presence, and catering to the growing demand for advanced toxicology testing solutions. The country's rising investments in healthcare and life sciences sectors further contribute to its dominance in the region. On the other hand, Germany is anticipated to lead the European market due to its rapidly growing pharmaceutical and medical industries, driving the demand for in-vitro toxicology testing products and services.
For more detailed information about the in-vitro toxicology testing market report, click here – https://www.databridgemarketresearch.com/fr/reports/global-vitro-toxicology-testing-market
